Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 5
2005 2
2007 6
2008 2
2009 1
2010 1
2011 5
2012 7
2013 6
2014 10
2015 13
2016 16
2017 11
2018 12
2019 9
2020 9
2021 16
2022 18
2023 12
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

153 results

Results by year

Filters applied: . Clear all
Page 1
Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A.
Ozelo MC, Mahlangu J, Pasi KJ, Giermasz A, Leavitt AD, Laffan M, Symington E, Quon DV, Wang JD, Peerlinck K, Pipe SW, Madan B, Key NS, Pierce GF, O'Mahony B, Kaczmarek R, Henshaw J, Lawal A, Jayaram K, Huang M, Yang X, Wong WY, Kim B; GENEr8-1 Trial Group. Ozelo MC, et al. Among authors: kim b. N Engl J Med. 2022 Mar 17;386(11):1013-1025. doi: 10.1056/NEJMoa2113708. N Engl J Med. 2022. PMID: 35294811 Clinical Trial.
Emicizumab Prophylaxis in Hemophilia A with Inhibitors.
Oldenburg J, Mahlangu JN, Kim B, Schmitt C, Callaghan MU, Young G, Santagostino E, Kruse-Jarres R, Negrier C, Kessler C, Valente N, Asikanius E, Levy GG, Windyga J, Shima M. Oldenburg J, et al. Among authors: kim b. N Engl J Med. 2017 Aug 31;377(9):809-818. doi: 10.1056/NEJMoa1703068. Epub 2017 Jul 10. N Engl J Med. 2017. PMID: 28691557 Free article. Clinical Trial.
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
Diabetic Retinopathy Clinical Research Network; Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW. Diabetic Retinopathy Clinical Research Network, et al. N Engl J Med. 2015 Mar 26;372(13):1193-203. doi: 10.1056/NEJMoa1414264. Epub 2015 Feb 18. N Engl J Med. 2015. PMID: 25692915 Free PMC article. Clinical Trial.
Breakdown.
Zhu JM, Hamel D, Dhaliwal G, Glass M, Sharpe B, Kim B, Monash B. Zhu JM, et al. Among authors: kim b. J Hosp Med. 2016 Feb;11(2):126-9. doi: 10.1002/jhm.2530. Epub 2016 Jan 22. J Hosp Med. 2016. PMID: 26800656 No abstract available.
Reply.
Parikh RN, Traband A, Kolomeyer AM, VanderBeek BL, Kim BJ, Maguire AM, Brucker AJ. Parikh RN, et al. Among authors: kim bj. Am J Ophthalmol. 2017 May;177:229. doi: 10.1016/j.ajo.2017.02.008. Epub 2017 Mar 18. Am J Ophthalmol. 2017. PMID: 28325547 No abstract available.
Starry sky.
Lee V, Kim BJ. Lee V, et al. Among authors: kim bj. JAMA Ophthalmol. 2014 Nov;132(11):1340. doi: 10.1001/jamaophthalmol.2014.563. JAMA Ophthalmol. 2014. PMID: 25210891 Free PMC article. No abstract available.
Emerging opportunities for C3 inhibition in the eye.
Kim BJ, Liu T, Mastellos DC, Lambris JD. Kim BJ, et al. Semin Immunol. 2022 Jan;59:101633. doi: 10.1016/j.smim.2022.101633. Epub 2022 Jul 2. Semin Immunol. 2022. PMID: 35787973 Review.
Multisystem diseases affecting the skin and eye.
Wanat KA, Kim B, Rosenbach M. Wanat KA, et al. Among authors: kim b. Clin Dermatol. 2016 Mar-Apr;34(2):214-41. doi: 10.1016/j.clindermatol.2015.11.013. Epub 2015 Nov 22. Clin Dermatol. 2016. PMID: 26903187 Review.
153 results